1. Home
  2. COCP vs RCG Comparison

COCP vs RCG Comparison

Compare COCP & RCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • RCG
  • Stock Information
  • Founded
  • COCP 2006
  • RCG 1994
  • Country
  • COCP United States
  • RCG United States
  • Employees
  • COCP N/A
  • RCG N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • RCG Investment Managers
  • Sector
  • COCP Health Care
  • RCG Finance
  • Exchange
  • COCP Nasdaq
  • RCG Nasdaq
  • Market Cap
  • COCP 15.4M
  • RCG 18.2M
  • IPO Year
  • COCP N/A
  • RCG N/A
  • Fundamental
  • Price
  • COCP $1.69
  • RCG $2.51
  • Analyst Decision
  • COCP Strong Buy
  • RCG
  • Analyst Count
  • COCP 1
  • RCG 0
  • Target Price
  • COCP $6.00
  • RCG N/A
  • AVG Volume (30 Days)
  • COCP 167.5K
  • RCG 5.9K
  • Earning Date
  • COCP 08-22-2025
  • RCG 01-01-0001
  • Dividend Yield
  • COCP N/A
  • RCG 0.98%
  • EPS Growth
  • COCP N/A
  • RCG N/A
  • EPS
  • COCP N/A
  • RCG N/A
  • Revenue
  • COCP N/A
  • RCG N/A
  • Revenue This Year
  • COCP N/A
  • RCG N/A
  • Revenue Next Year
  • COCP N/A
  • RCG N/A
  • P/E Ratio
  • COCP N/A
  • RCG N/A
  • Revenue Growth
  • COCP N/A
  • RCG N/A
  • 52 Week Low
  • COCP $1.12
  • RCG $1.52
  • 52 Week High
  • COCP $3.26
  • RCG $1.90
  • Technical
  • Relative Strength Index (RSI)
  • COCP 48.54
  • RCG 41.33
  • Support Level
  • COCP $1.56
  • RCG $2.52
  • Resistance Level
  • COCP $1.67
  • RCG $2.62
  • Average True Range (ATR)
  • COCP 0.14
  • RCG 0.06
  • MACD
  • COCP -0.02
  • RCG -0.01
  • Stochastic Oscillator
  • COCP 11.90
  • RCG 1.89

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About RCG RENN Fund Inc

RENN Fund Inc is active in the financial services domain. It is a a registered, non-diversified, closed-end management investment company formed to provide return through capital appreciation and income by a long-term, value-oriented investment process that invests in a wide variety of financial instruments, including but not limited to, common stocks, fixed-income securities including convertible and non-convertible debt securities or loans, distressed debt, warrants, and preferred stock, exchange-traded funds and exchange-traded notes, and other instruments. It invests in various industries, including communication services, surgical and medical instruments and apparatus, oil and gas, medical chemicals, botanical products, etc.

Share on Social Networks: